Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gillatt

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Cancer Research|July 19, 2002
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinomaDavid O Bates, Tai-Gen Cui, Joanne M Doughty, et al.
International Journal of Cancer|January 9, 2004
Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control studySteven E Oliver, David Gunnell, Jenny Donovan, et al.
Journal of Clinical Epidemiology|August 19, 2003
Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study)Jenny L Donovan, Tim J Peters, Sian Noble, et al.
Oncotarget|October 7, 2016
Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapyJingli Hao, Peter Graham, Lei Chang, et al.
Urology|August 11, 2004
Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screeningSteven E Oliver, Jeff Holly, Tim J Peters, et al.
Cancers|January 8, 2020
Rapid and Label-Free Isolation of Tumour Cells from the Urine of Patients with Localised Prostate Cancer Using Inertial MicrofluidicsAlexey S Rzhevskiy, Sajad Razavi Bazaz, Lin Ding, et al.
Journal of Clinical Epidemiology|July 16, 2008
Development of a complex intervention improved randomization and informed consent in a randomized controlled trialJenny L Donovan, J Athene Lane, Tim J Peters, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancerSteven E Oliver, Barney Barrass, David J Gunnell, et al.
BJU International|June 11, 2008
The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort studyChris Metcalfe, Biral Patel, Simon Evans, et al.
European Urology|March 21, 2007
The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort studyYoav Ben-Shlomo, Simon Evans, Fowzia Ibrahim, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Cancer Research|July 19, 2002
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinomaDavid O Bates, Tai-Gen Cui, Joanne M Doughty, et al.
International Journal of Cancer|January 9, 2004
Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control studySteven E Oliver, David Gunnell, Jenny Donovan, et al.
Journal of Clinical Epidemiology|August 19, 2003
Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study)Jenny L Donovan, Tim J Peters, Sian Noble, et al.
Oncotarget|October 7, 2016
Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapyJingli Hao, Peter Graham, Lei Chang, et al.
Urology|August 11, 2004
Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screeningSteven E Oliver, Jeff Holly, Tim J Peters, et al.
Cancers|January 8, 2020
Rapid and Label-Free Isolation of Tumour Cells from the Urine of Patients with Localised Prostate Cancer Using Inertial MicrofluidicsAlexey S Rzhevskiy, Sajad Razavi Bazaz, Lin Ding, et al.
Journal of Clinical Epidemiology|July 16, 2008
Development of a complex intervention improved randomization and informed consent in a randomized controlled trialJenny L Donovan, J Athene Lane, Tim J Peters, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancerSteven E Oliver, Barney Barrass, David J Gunnell, et al.
BJU International|June 11, 2008
The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort studyChris Metcalfe, Biral Patel, Simon Evans, et al.
European Urology|March 21, 2007
The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort studyYoav Ben-Shlomo, Simon Evans, Fowzia Ibrahim, et al.
Pageof 7